Key facts
- Xander’s last known valuation is $15.0M (Aug 2024).
- It has raised $2.8M; the latest was Seed Round in Sep 2025.
- Notable investors include Creative Destruction Lab, SBXi, NC Tweener Fund, Massachusetts Institute of Technology, AgeTech Collaborative from AARP — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Xander
- ·The full record, as it builds
Funding rounds
No funding rounds for Xander are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Xander
Developer of a hearing aid device designed using augmented reality to improve interpersonal communication and mitigate the debilitating effects of hearing loss decrease cognitive load and improve mental state. The company's device offers captions for conversations in real-time, noise-canceling microphones, integrated touchpads, rechargeable batteries, and speech-to-text technology, which are lightweight, comfortable, and safe, people with hearing loss who seek alternatives to hearing aids and other assistive devices, enabling the wearer to look at the people speaking and participate fully in the conversation.
- Sector
- Healthcare
- HQ
- Somerville, MA, United States
- Founded
- 2020
- Employees
- 10
- Website
- xanderglasses.com/
- Ownership
- Privately Held (backing)
Xander doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Xander shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Xander in its N-PORT filings yet. We sweep new filings monthly.